Biomedical subjects
Publications and source records attributed to J Zieleński.
A family is described in which an apparent Ay phenotype was transmitted through 2 generations. We favor a mutation of the A allele as the most likely cause of the phenotype. Activities of the serum A-gene-specified transferase were not detected in any of the 3 family members with the Ay phenotypes.
Explore the source record for details and available documents.
Explore the source record for details and available documents.
Explore the source record for details and available documents.
A high galactosyltransferase activity with lactotriaosylceramide as acceptor has been found in human serums. The reaction requires UDP-galactose, Mn2+, and Triton X-100. It has a pH optimum of 6.0 and a Km for lactotriaosylceramide of 0.66 mM. On the basis of methylation analysis and susceptibility towards beta-galactosidase the reaction product has been identified as neolactotetraosylceramide. Lactotetraosylceramide formation was not observed. Evidence is presented that the serum enzymic activity can be attributed to N-acetyllactosamine synthase (EC 2.4.1.90). The beta 1 leads to 4-galactosyltransferase activities with lactotriaosylceramide as acceptor have been determined in different human sera. The activity is independent of ABO, p and Rh blood-group status. The enzyme is within a normal range in serums of cancer patients.
Major neutral glycosphingolipids were isolated from human plasma and their structures and fatty acid compositions studied. The four neutral glycosphingolipids of plasma were characterized as Glc beta(1 leads to 1)ceramide, Gal beta(1 leads to 1)- ceramide, Gal beta(1 leads to 4) Glc beta (1 leads to 1)ceramide, Gal alpha(1 leads to 4) Gal beta(1 leads to 4) Glc beta(1 leads to 1)ceramide and GalNAc beta(1 leads to 3) Gal (1 leads to 4) Gal (1 leads to 4) Glc beta(1 leads to 1)-ceramide. The glycosphingolipids contained mostly short chain fatty acids of which most prominent was C16. Erythrocyte glucosylceramide and lactosylceramide exhibited similar fatty acid compositions as their plasma counterparts. Triglycosylceramide and globoside of erythrocytes contained almost exclusively long-chain fatty acids. In lactosylceramide obtained from "p" erythrocytes, an accumulation of long-chain fatty acids was found; this accumulation was not observed, however, in lactosylceramide isolated from "p" plasma. It was concluded that plasma and erythrocyte glycosphingolipids are synthesized at separate sites where short- and long-chain fatty acids, respectively, are available. Plasma and erythrocyte glucosylceramide, and probably a fraction of lactosylceramide, exchange between plasma and erythrocyte pools. The latter conclusion is discussed in the light of the relative roles of carbohydrate and lipid moieties of the glycosphingolipids in maintaining their association with erythrocyte membranes.
Explore the source record for details and available documents.
1. Susceptibility to inhibitors of neutral protease from calf thymus chromatin has been compared with that of trypsin. The chromatin protease reacts stoichiometrically with the inhibitors specific for trypsin (diisopropylfluorophosphate, tosyl-lysyl chloromethane, soybean trypsin inhibitor and Kunitz basic inhibitor from pancreas), but not with the inhibitor specific for chymotrypsin (tosyl-phenylalanyl chloromethane). 2. Chromatin protease, similarly as trypsin, cleaves Lys-X and Arg-X peptide bonds. 3. It is concluded that the structure of active site region of both enzymes is very similar.
Poly/glycosyl/ceramides, highly complex and blood-group active glycosphingolipids of human erythrocyte membranes were subjected to SDS polyacrylamide gel electrophoresis. The substances exhibited similar electrophoretic mobilities as membrane sialoglycoproteins.